News

Physician's Weekly1d
Peripheral Intravenous Catheter Replacement Should Be Considered After 3 Days
Bloodstream infection risk rises sharply after 3 days of peripheral IV catheter use, suggesting replacement by day 4 may help prevent serious complications.
UroGen Pharma Receives FDA Approval for ZUSDURI for Recurrent Bladder Cancer
UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...
Targeted Oncology6d
TAR-200 Offers New Hope for BCG-Unresponsive Bladder Cancer
Joseph Jacob, MD, discusses the promising impact of TAR-200.
qualitysafety.bmj5d
Economic evaluation of quality improvement interventions to prevent catheter-associated urinary tract infections in the hospital setting: a systematic review
Background Hospitals have implemented diverse quality improvement (QI) interventions to reduce rates of catheter-associated urinary tract infections (CAUTIs). The economic value of these QI ...